Last reviewed · How we verify

corticosteroids (Aprednislon) — Competitive Intelligence Brief

corticosteroids (Aprednislon) (corticosteroids (Aprednislon)) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Corticosteroid (glucocorticoid). Area: Immunology / Rheumatology / General anti-inflammatory.

marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR) Immunology / Rheumatology / General anti-inflammatory Small molecule Live · refreshed every 30 min

Target snapshot

corticosteroids (Aprednislon) (corticosteroids (Aprednislon)) — Ingrid Pabinger, MD. Aprednislon is a corticosteroid that suppresses immune and inflammatory responses by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
corticosteroids (Aprednislon) TARGET corticosteroids (Aprednislon) Ingrid Pabinger, MD marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR)
Triamcinolone Acetonide (TA) Triamcinolone Acetonide (TA) Rumah Sakit Pusat Angkatan Darat Gatot Soebroto marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor
Corticosteroids (Prednisone) Corticosteroids (Prednisone) Astellas Pharma Inc marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR)
Prednisolone, prednisone, or methylprednisolone Prednisolone, prednisone, or methylprednisolone Children's Hospital of Philadelphia marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR)
phosphate and betamethasone acetate, 2 mL. phosphate and betamethasone acetate, 2 mL. Hospital Italiano de Buenos Aires marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR)
Methyl Prednisolonate Methyl Prednisolonate Ain Shams University marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR)
prednison, Azenil prednison, Azenil Tel-Aviv Sourasky Medical Center marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Corticosteroid (glucocorticoid) class)

  1. Assistance Publique - Hôpitaux de Paris · 3 drugs in this class
  2. Astellas Pharma Inc · 2 drugs in this class
  3. Sanofi · 2 drugs in this class
  4. Xinqiao Hospital of Chongqing · 2 drugs in this class
  5. Berinstein, Jeffrey · 2 drugs in this class
  6. Ain Shams University · 2 drugs in this class
  7. Children's Hospital of Philadelphia · 1 drug in this class
  8. Celgene · 1 drug in this class
  9. Hamilton Health Sciences Corporation · 1 drug in this class
  10. Erasme University Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). corticosteroids (Aprednislon) — Competitive Intelligence Brief. https://druglandscape.com/ci/corticosteroids-aprednislon. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing